Back to search
Haemophilus Influenzae Meningitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Haemophilus Influenzae Meningitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Haemophilus Influenzae Meningitis trials you may qualify forBacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibil…
This clinical trial is conducted in two parts. Part One employs a randomized, partially blinded, dose-escalation, partially active-controlled design. Part Two u…
Antibody deficiencies and complement deficiencies are the most frequent Primary immunodeficiencies (PIDs) in adults, and are associated with greatly increased s…
The purpose of this study is to evaluate immunogenicity of BK1310 for all antigens (anti-PRP, diphtheria toxin, pertussis, tetanus toxin, and polio virus), afte…
Haemophilus influenzae serotype a (Hia) has emerged as a leading cause of serious illness in Indigenous children in Canada and Alaska in recent decades. In hosp…